Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 79961

1.

WHO Global Rotavirus Surveillance Network: A Strategic Review of the First 5 Years, 2008-2012.

Agócs MM, Serhan F, Yen C, Mwenda JM, de Oliveira LH, Teleb N, Wasley A, Wijesinghe PR, Fox K, Tate JE, Gentsch JR, Parashar UD, Kang G; Department of Immunization, Vaccines, and Biologicals, World Health Organization (WHO), Geneva, Switzerland.

MMWR Morb Mortal Wkly Rep. 2014 Jul 25;63(29):634-637.

PMID:
25055187
[PubMed - as supplied by publisher]
2.

National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2013.

Elam-Evans LD, Yankey D, Jeyarajah J, Singleton JA, Curtis RC, MacNeil J, Hariri S; Immunization Services Division, National Center for Immunization and Respiratory Diseases.

MMWR Morb Mortal Wkly Rep. 2014 Jul 25;63(29):625-633.

PMID:
25055186
[PubMed - as supplied by publisher]
3.

Human Papillomavirus Vaccination Coverage Among Adolescents, 2007-2013, and Postlicensure Vaccine Safety Monitoring, 2006-2014 - United States.

Stokley S, Jeyarajah J, Yankey D, Cano M, Gee J, Roark J, Curtis RC, Markowitz L; Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC.

MMWR Morb Mortal Wkly Rep. 2014 Jul 25;63(29):620-624.

PMID:
25055185
[PubMed - as supplied by publisher]
4.

Vaccines for preventing herpes zoster in older adults.

Gagliardi AM, Silva BN, Torloni MR, Soares BG.

Sao Paulo Med J. 2014;132(4):255.

PMID:
25055074
[PubMed - as supplied by publisher]
5.

Evolving role of tumor antigens for future melanoma therapies.

Andrews MC, Woods K, Cebon J, Behren A.

Future Oncol. 2014 Jun;10(8):1457-68. doi: 10.2217/fon.14.84.

PMID:
25052755
[PubMed - in process]
6.

Comparative efficacy of two next-generation Rift Valley fever vaccines.

Kortekaas J, Oreshkova N, van Keulen L, Kant J, Bosch BJ, Bouloy M, Moulin V, Goovaerts D, Moormann RJ.

Vaccine. 2014 Jul 19. pii: S0264-410X(14)00978-5. doi: 10.1016/j.vaccine.2014.07.037. [Epub ahead of print]

PMID:
25050973
[PubMed - as supplied by publisher]
7.

Vaccination: an evolutionary engine for pathogens? Conference report.

Soubeyrand B, Greenberg M, Tibayrenc M, Louis J, Dutel C, Simondon F, Saadatian-Elahi M.

Infect Genet Evol. 2014 Jul 19. pii: S1567-1348(14)00236-6. doi: 10.1016/j.meegid.2014.07.007. [Epub ahead of print]

PMID:
25050487
[PubMed - as supplied by publisher]
8.

Induction of Cytomegalovirus-Specific T Cell Responses in Healthy Volunteers and Allogeneic Stem Cell Recipients Using Vaccination With Messenger RNA-Transfected Dendritic Cells.

Van Craenenbroeck AH, Smits EL, Anguille S, Van de Velde A, Stein B, Braeckman T, Van Camp K, Nijs G, Ieven M, Goossens H, Berneman ZN, Van Tendeloo VF, Verpooten GA, Van Damme P, Cools N.

Transplantation. 2014 Jul 21. [Epub ahead of print]

PMID:
25050468
[PubMed - as supplied by publisher]
9.

Dual therapeutic benefit of electroporation-mediated DNA vaccination in vivo: Enhanced gene transfer and adjuvant activity.

Calvet CY, André FM, Mir LM.

Oncoimmunology. 2014 Apr 29;3:e28540. eCollection 2014.

PMID:
25050220
[PubMed]
10.

The protective effectiveness of an inactivated bovine ephemeral fever virus vaccine.

Aziz-Boaron O, Gleser D, Yadin H, Gelman B, Kedmi M, Galon N, Klement E.

Vet Microbiol. 2014 Jul 2. pii: S0378-1135(14)00313-7. doi: 10.1016/j.vetmic.2014.06.021. [Epub ahead of print]

PMID:
25048620
[PubMed - as supplied by publisher]
11.

Procedures for Mucosal Immunization and Analyses of Cellular Immune Response to Candidate HIV Vaccines in Murine and Nonhuman Primate Models.

Singh S, Nehete P, Hanley P, Nehete B, Yang G, He H, Anthony SM, Schluns KS, Sastry KJ.

Methods Mol Biol. 2014;1184:417-55. doi: 10.1007/978-1-4939-1115-8_24.

PMID:
25048139
[PubMed - in process]
12.

Modeling the Impact of Climate and Landscape on the Efficacy of White Tailed Deer Vaccination for Cattle Tick Control in Northeastern Mexico.

Estrada-Peña A, Carreón D, Almazán C, de la Fuente J.

PLoS One. 2014 Jul 21;9(7):e102905. doi: 10.1371/journal.pone.0102905. eCollection 2014.

PMID:
25047078
[PubMed - as supplied by publisher]
Free Article
13.

Comparison of the safety and immunogenicity of an MF59®-adjuvanted with a non-adjuvanted seasonal influenza vaccine in elderly subjects.

Frey SE, Reyes MR, Reynales H, Bermal NN, Nicolay U, Narasimhan V, Forleo-Neto E, Arora AK.

Vaccine. 2014 Jul 18. pii: S0264-410X(14)00939-6. doi: 10.1016/j.vaccine.2014.07.013. [Epub ahead of print]

PMID:
25045825
[PubMed - as supplied by publisher]
14.

Seasonal influenza vaccination trends from 2007-2011 in privately insured children and adults in the United States.

Antonova E, Ambrose CS, Kern D, Block SL, Caspard H, Tunceli O.

Vaccine. 2014 Jul 18. pii: S0264-410X(14)00935-9. doi: 10.1016/j.vaccine.2014.07.009. [Epub ahead of print]

PMID:
25045823
[PubMed - as supplied by publisher]
15.

Issues and considerations in the use of serologic biomarkers for classifying vaccination history in household surveys.

MacNeil A, Lee CW, Dietz V.

Vaccine. 2014 Jul 18. pii: S0264-410X(14)00931-1. doi: 10.1016/j.vaccine.2014.07.005. [Epub ahead of print] Review.

PMID:
25045821
[PubMed - as supplied by publisher]
16.

Influenza vaccine as prevention for cardiovascular diseases: Possible molecular mechanism.

Veljkovic V, Glisic S, Veljkovic N, Bojic T, Dietrich U, Perovic VR, Colombatti A.

Vaccine. 2014 Jul 18. pii: S0264-410X(14)00933-5. doi: 10.1016/j.vaccine.2014.07.007. [Epub ahead of print]

PMID:
25045818
[PubMed - as supplied by publisher]
17.

Development of an HIV vaccine attitudes scale to predict HIV vaccine acceptability among vulnerable populations: L.A. VOICES.

Lee SJ, Newman PA, Duan N, Cunningham WE.

Vaccine. 2014 Jul 18. pii: S0264-410X(14)00944-X. doi: 10.1016/j.vaccine.2014.07.018. [Epub ahead of print]

PMID:
25045817
[PubMed - as supplied by publisher]
18.

Neutralizing and cross-neutralizing antibody titres induced by bivalent and quadrivalent human papillomavirus vaccines in the target population of organized vaccination programmes.

Barzon L, Squarzon L, Masiero S, Pacenti M, Marcati G, Mantelli B, Gabrielli L, Lazzarotto T, Caputo A, Palù G.

Vaccine. 2014 Jul 18. pii: S0264-410X(14)00940-2. doi: 10.1016/j.vaccine.2014.07.014. [Epub ahead of print]

PMID:
25045814
[PubMed - as supplied by publisher]
19.

Improving the Th1 cellular efficacy of the lead Yersinia pestis rF1-V subunit vaccine using SA-4-1BBL as a novel adjuvant.

Dinc G, Pennington JM, Yolcu ES, Lawrenz MB, Shirwan H.

Vaccine. 2014 Jul 18. pii: S0264-410X(14)00941-4. doi: 10.1016/j.vaccine.2014.07.015. [Epub ahead of print]

PMID:
25045812
[PubMed - as supplied by publisher]
20.

Active surveillance of adverse events following childhood immunization in Singapore.

Thoon KC, Soh SB, Liew WK, Gunachandran A, Tan NW, Chong CY, Yung CF.

Vaccine. 2014 Jul 18. pii: S0264-410X(14)00946-3. doi: 10.1016/j.vaccine.2014.07.020. [Epub ahead of print]

PMID:
25045811
[PubMed - as supplied by publisher]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk